| 摘要 |
The present invention provides immunoresponsive cells, including T cells, cytotoxic T cells, regulatory T cells, and Natural Killer (NK) cells, expressing at least one of an antigen recognizing receptor and a co-stimulatory ligand and methods of use therefore for the treatment of neoplasia and other pathologies where an increase in an antigen-specific immune response is desired. a b M, x2& I o KT 0tc IN~t WN w tz~ m W - ------ ymir '8 ,:Ma m MA- , r |
